SCHEMBL17816185

SCHEMBL17816185

O=C(Nc1ccc(F)c(Cl)c1)c1ccc(I)c(SC2CCCC(C(=O)O)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
NPSR1 Q6W5P4 1/20 0.43
KMT2A Q03164 3/20 0.41
NR1I2 O75469 1/20 0.41
AHR P35869 1/20 0.41
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 2/20 0.41
GAA P10253 1/20 0.41
MAOB P27338 3/20 0.41
MAPT P10636 1/20 0.41
KCNQ3 O43525 1/20 0.40
KCNQ2 O43526 1/20 0.40
KCNE1 P15382 1/20 0.40
KCNQ1 P51787 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
MAOA P21397 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17816145 0.96 NPC1 (0.49) NPC1RAB9ANPSR1KMT2ANR1I2
SCHEMBL17792187 0.93 NPC1 (0.49) NPC1RAB9ANPSR1KMT2ANR1I2
SCHEMBL17816122 0.91 NPC1 (0.47) NPC1RAB9ANPSR1KMT2ANR1I2
SCHEMBL17816138 0.90 NPC1 (0.50) NPC1RAB9ANPSR1KMT2AALDH1A1
SCHEMBL17792169 0.89 NPC1 (0.53) NPC1RAB9ANPSR1KMT2ANR1I2
SCHEMBL17816153 0.88 NPC1 (0.50) NPC1RAB9ANPSR1KMT2ANR1I2
SCHEMBL17816124 0.88 NPC1 (0.46) NPC1RAB9ASMN1; SMN2MAOBKCNQ3
SCHEMBL17816106 0.87 NPC1 (0.49) NPC1RAB9ANPSR1KMT2ANR1I2
SCHEMBL17816104 0.86 NPC1 (0.47) NPC1RAB9ANPSR1KMT2AALDH1A1
SCHEMBL19479142 0.85 NPC1 (0.49) NPC1RAB9ANPSR1KMT2ANR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016089990-A1 SULFIDE ALKYL AND PYRIDYL REVERSE SULFONAMIDE COMPOUNDS FOR HBV TREATMENT NOVIRA THERAPEUTICS, INC. (US) 2016-06-09 WO disclosed